Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bipolar Disorder × drospirenone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 6 Overweight 1 Observational Study 1 Metabolic Syndrome 1 Insulin Resistance 1 Infertility 1 Depression 1 Bipolar Disorder 1 Anxiety Disorders 1 Advanced Malignancies 1

Interventions

ziprasidone 1 drospirenone 1 Zolpidem 1 Warfarin 1 Venlafaxine Hydrochloride 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Surveys and Questionnaires 1 Spironolactone 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Metformin 1 Medical Marijuana 1 Lurasidone Hydrochloride 1 Labetalol 1 Infliximab 1 Haloperidol 1 Gabapentin 1 Fosfomycin 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04984070 2022-10-05

PCOS

Fudan University

Phase NA Unknown

Anxiety Disorders, Bipolar Disorder, Depression, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡